|
|||||
SangCyaActive Ingredient(s): CyclosporineFirst Approved by the FDA: October 31, 1998 Pharmaceutical Company: SANGSTAT MEDCL Possible Dosages for this and Related Drugs:Note: May Include Dosages for Drugs similar to SangCyaCapsule 100mg, 25mg, 50mg Emulsion 0.05% Injection 250mg/5ml, 50mg/ml Solution 100mg/ml Related Drug Page(s): Related Search Results for SangCyaWebmasters or Publishers: Link To This Drug ListingCopy and Paste the HTML Code Below to Create a Link to this Listing from any Web Page or Email.Graphical Link:
Graphical Link HTML Code: Text Link: Learn About SangCya Text Link HTML Code: Related: SangCya study types, withdrawal studies list overdosage encyclopedia SangCya, title name warnings natural SangCya, pills lookup pills measure SangCya, SangCya internal, symptoms treat dictionary class SangCya, digest SangCya, overdosage label SangCya, SangCya list description monograph value, alternative encyclopedia history SangCya. Cyclosporine description types institute side effects reactions, Cyclosporine internal technical guide pharmacology, Cyclosporine substance treat treat study addiction, reference ingredients definition Cyclosporine, Cyclosporine facts forums foreign capsule precautions, Cyclosporine help withdrawal answers research information. Return to Top Start a New Discussion About this DrugThis information has been independently compiled and is for educational purposes only. It is not intended to be a substitute for professional medical advice. Please remember that the content within this community is totally compiled by users of this site. Our website displays many pages which do not contain any medical information regarding the drug name stated. These pages are only provided for the purpose of opening community discussions about that drug by our users. For more details please see the Disclaimer. This data is Copyright © 2005-2008 PrescriptionDrug-Info.com and is protected under U.S. and International Copyright laws. All Rights Reserved. Drugs/SangCya.asp Last Updated June 27 2005 |
|||||